Non-adherence group (N = 219) | Less adherence group (N = 674) | Greater adherence group (N = 90) | |||||||
---|---|---|---|---|---|---|---|---|---|
aOR | 95% CI | P value | aOR | 95% CI | P value | aOR | 95% CI | P value | |
Regiona | |||||||||
East Asia | 1.05 | 0.42–2.63 | .91 | 0.32 | 0.17–0.60 | < .001 | 1.18 | 0.39–3.52 | .77 |
West Asia | 1.96 | 0.82–4.73 | .13 | 1.11 | 0.65–1.92 | .70 | 0.53 | 0.14–1.08 | .34 |
North and South America | 0.58 | 0.19–1.76 | .34 | 0.39 | 0.20–0.76 | .005 | 1.39 | 0.45–4.35 | .58 |
Northern Europe | 0.84 | 0.37–1.93 | .69 | 0.81 | 0.50–1.33 | .41 | 0.64 | 0.22–1.81 | .40 |
Western Europe | 2.34 | 1.01–5.42 | .05 | 1.66 | 0.99–2.78 | .06 | 1.47 | 0.50–4.30 | .48 |
Southern Europe | 1.38 | 0.59–3.21 | .46 | 0.92 | 0.56–1.53 | .75 | 0.62 | 0.21–1.85 | .39 |
Eastern Europe | 2.44 | 0.97–6.16 | .06 | 1.98 | 1.11–3.54 | .02 | 0.21 | 0.02–1.92 | .17 |
Others | [Reference] | [Reference] | [Reference] | ||||||
Sex | |||||||||
Male | 2.34 | 1.64–3.35 | < .001 | 1.02 | 0.77–1.34 | .92 | 1.84 | 0.98–3.08 | .05 |
Female | [Reference] | [Reference] | [Reference] | ||||||
Age in years | |||||||||
Young adults (18–30 years) | 1.44 | 0.67–3.13 | .35 | 1.30 | 0.83–2.01 | .25 | .746 | 0.31–1.78 | .51 |
Middle-aged (31–59 years) | 1.02 | 0.48–2.17 | .96 | 1.21 | 0.80–1.84 | .36 | .745 | 0.33–1.69 | .48 |
Older adults (≥ 60 years) | [Reference] | [Reference] | [Reference] | ||||||
Infected by COVID-19 | |||||||||
Yes/ have symptoms | 2.37 | 1.55–3.63 | < .001 | 1.35 | 0.99–1.84 | .06 | 1.31 | 0.66–2.60 | .44 |
No symptoms | [Reference] | [Reference] | [Reference] | ||||||
Motivating factors | |||||||||
Self-efficacy | 0.74 | 0.71–0.77 | < .001 | 0.93 | 0.91–0.96 | < .001 | 0.88 | 0.84–1.05 | .05 |
Perceived susceptibility | 0.93 | 0.88–0.99 | .02 | 0.96 | 0.93–1.00 | .04 | 0.94 | 0.87–1.01 | .10 |
Perceived severity | 0.90 | 0.85–0.94 | < .001 | 0.96 | 0.93–0.99 | .02 | 1.00 | 0.92–1.07 | .90 |
Prosociality | 0.85 | 0.81–0.89 | .008 | 0.77 | 0.75–0.79 | .04 | 0.97 | 0.92–1.03 | .31 |
Perceived social support | 1.00 | 0.93–1.09 | .95 | 1.028 | 0.98–1.08 | .32 | 1.01 | 0.90–1.14 | .82 |